Effect of Chi-alg Encapsulated 6% Curcumin Isolated from Mother Rhizome on Diabetes Mellitus in L6 Cell Lines

Main Article Content

Y. Swarnalatha

Abstract

Introduction: In this study, antidiabetic activity of 6% curcumin and chi-alg-encapsulated 6% curcumin isolated from the curumina longa (commonly called as turmeric) mother rhizome were evaluated and compared. Materials and Methods: The 6% curcumin-chi-alg encapsulated nanoparticles were prepared and characterized using scanning electron microscope and Fourier transform infrared. The antidiabetic activity of 6% curcumin was estimated in L6 cell lines. Cell viability was assessed using (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, and 3T3L1 antiadipogenesis assay was performed and in-vitro α-amylase activity was done. Results and Discussion: The chi-alg encapsulated curcumin found to possess the maximum antidiabetic activity. Encapsulated curcumin demonstrated better α-amylase inhibition activity than curcumin alone with inhibitory concentration 50% value of 36.81 μg/ml. The encapsulated curcumin reduced the lipid accumulation in differentiated adipocytes. Increase in the 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose uptake by the cells cumulatively reflects the uptake of the glucose by encapsulated curcumin treatment. Conclusion: The current results suggest that the chi-alg encapsulated curucmin exhibit its antidiabetic activity by various types of mechanisms, including enhancing the glucose uptake by adipose tissue, suppresses the adipogenesis.

Downloads

Download data is not yet available.

Article Details

How to Cite
Swarnalatha, Y. (2016). Effect of Chi-alg Encapsulated 6% Curcumin Isolated from Mother Rhizome on Diabetes Mellitus in L6 Cell Lines. Asian Journal of Pharmaceutics (AJP), 10(03). https://doi.org/10.22377/ajp.v10i03.768
Section
ORIGINAL ARTICLES